SYRE R&D Expenses

Spyre Therapeutics Inc · R&D Expenses

SYRE logo

SYRE R&D Expenses

Latest reported$215.80M
SYRE R&D Expenses ($6.83M → $215.80M)
High-resolution chart · PNG

SYRE r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
171,653,000
162,790,000
89,504,000
58,579,000
57,069,000
59,638,000
64,600,000
36,719,000
22,815,000
18,143,000
11,453,000
6,830,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.